chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Dose 1 was given on 10-May-2021 and dose 2 was given on 22-Jun-2021; This spontaneous case was reported by an other health care professional and describes the occurrence of INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Dose 1 was given on 10-May-2021 and dose 2 was given on 22-Jun-2021) in a 42-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 053C21A and 022C21A) for COVID-19 prophylaxis.     It was unknown if the patient had any allergies to medications, food and other products. It was unknown if the patient was ever been diagnosed with or tested positive for COVID-19. It was also unknown if the patient had any acute illnesses at the time of vaccination and up to one month before.  Concurrent medical conditions included Blood pressure high (No recent changes in condition status).   On 10-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .5 milliliter. On 22-Jun-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to .5 milliliter. On 22-Jun-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Dose 1 was given on 10-May-2021 and dose 2 was given on 22-Jun-2021). At the time of the report, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Dose 1 was given on 10-May-2021 and dose 2 was given on 22-Jun-2021) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   It was unknown if any prescription medications, over-the-counter medications, dietary supplements or herbal remedies were taken by the patient at time of vaccination and/or at the time of the adverse event.  No treatment information was provided by the reporter.   This case was linked to MOD-2022-585601 (Patient Link).
LEFT EYE DRAINING, FELT LIKE THERE WAS A LOT OF DIRT IN IT; SINUS RUNNING AS EXCESSIVE DRAINING; This spontaneous report received from a patient concerned a 56 year old of unspecified sex. The patient's height, and weight were not reported. The patient's pre-existing medical conditions included the patient had no history of sinus. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: unknown) dose was not reported, administered on 23-JUL-2021 for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported. On 24-JUL-2021, the subject experienced left eye draining, felt like there was a lot of dirt in it. On 24-JUL-2021, the subject experienced sinus running as excessive draining. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from left eye draining, felt like there was a lot of dirt in it, and sinus running as excessive draining. This report was non-serious.
Autism Spectrum Disorder, post vax. Pt stopped talking, sitting up and seemed to not recognize daily items, like his spoon. Autistic.
The symptoms started at 4:00 am a few days after the shot and I was having diarrhea and soreness on my arms.  I was also feeling lethargic and fatigue.  I went to an urgent care clinic and they gave me water and told me to lay down and instructed me to follow up with my physician and he has been sick and have not been able to see him but I have an appointment for 10/7/22.  I am still feeling tired today and I have been resting due to the dizzy feeling I have been having.  I have not been able to go to my exercise class because I have not been feeling well, maybe Monday I will be able to go. I don't want to go to the ED because the wait is like 12 hours and that would be too strenuous on me.
Patient tested positive for Covid-19 on 12/18/21 and died on 1/17/22
Narrative:  Pt received first dose of Pfizer COVID-19 vaccine on 3/9 and developed almost immediate tachycardia, borderline high blood pressure, flushing. She was seen at hospital and fluid resuscitated along with labs, EKG. Her d-dimer was elevated in the 300s and had negative Duplex and CTA pulmonary angio to r/o PE. Records have been requested. Few days after vaccination, HR remained elevated 90-105 at rest, 115-130 walking, standing. mild fever has now resolved. Pt had history of COVID-19 with hospitalization and sepsis in 12/2020. Consults with Dr. suggests reaction is not anaphylaxis but a stronger reaction to the vaccine due to previous history of infection.
Consumer was refused his second dose of the Pfizer BioNTech covid-19 vaccine; about a week and a half before his second, dose he had a fall; This is a spontaneous report from a contactable consumer (patient reported for self). A 74-year-old male patient received first dose of bnt162b2 (BNT162B2, PFIZER-BIONTECH COVID-19 VACCINE, Batch/Lot number: EN6201), via an unspecified route of administration, administered in arm right on 24Feb2021 (at the age of 74-year-old) as DOSE 1, SINGLE for COVID-19 immunization. The patient medical history included artificial heart valve. Concomitant medications included isosorbide dinitrate, sotalol, nitroglycerin, warfarin deanol, atorvastatin calcium and tramadol. On an unspecified date, the patient reported that before his second dose (of Covid19 vaccine), he had a fall and had to go to the ER and they gave him a tetanus booster and he was refused his second dose of the Pfizer BioNTech covid-19 vaccine. When patient went in for his first dose and was scheduled for his second dose and about a week and a half before his second, dose he had a fall and had to go to the ER and they gave him a tetanus booster and so when second dose appointment arrived, the pharmacist said "you had another vaccination within 2 weeks. We can't give you this dose". Adverse event (fall) required a visit to the emergency room. The outcome of the events was unknown.  No follow-up attempts are needed. No further information is expected.
Patient had a large local reaction at injection site requiring prednisolone 15mg/5ml oral steroid and betamethasone 0.05% topical steroid to be prescribed. After steroids, symptoms resolved.
Swollen arm & forearm, pain, nausea & vomiting x 3 days;
For 3-4 days after the vaccine, I had only arm soreness @ the injection site. That eventually faded. Exactly one week to the day after the vaccine, the injection site started itching. Then 8 days after the vaccine, the injection site got very hard and red and hot to the touch. Today is the 11th day after the vaccine, and it continues to be red hot and itchy. The patch has grown in size.
Arm red, swollen, tender to touch, itchy.  Area involved 19cm x 21cm.
This spontaneous report was received from a certified medical assistant and refers to an unspecified number of patients of unknown age and gender. There was no information about the patients' concurrent conditions, concomitant therapies or medical histories provided. On unknown dates between 19-APR-2017 and 23-MAY-2017, the patients were vaccinated with improperly stored doses of    PNEUMOVAX23 lot # M038359 with expiration date 13-MAY-2018 (dose and route of administration were not reported). There was no adverse effect reported. Administered doses of vaccines experienced the temperature excursion between 32 and 35 degrees Fahrenheit for 24 hours. A Digital Data logger was not involved. There were no previous temperature excursions reported. This is one of several reports received from the same reporter. Additional information has been requested.; Sender's Comments: US-009507513-1705USA014464: US-009507513-1705USA014494: US-009507513-1705USA014495: US-009507513-1705USA014497:
I received my second vaccine at 12:00 pm on August 26, 2021. Around 6:00 the muscle spasms in my feet, legs, and hands started. By 8:00 that evening, I just wasn't feeling well so I went to bed early. I woke up around midnight vomiting, total body aches, and had a 103.4 degree fever. I took Tylenol and went back to bed. I slept through the day on the 27th and struggled keeping my fever down with medicine. The fever, aches, chills, and fatigue lasted through the day and night.
Soreness in arm of injection; Redness in arm of injection; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (Soreness in arm of injection) and VACCINATION SITE ERYTHEMA (Redness in arm of injection) in a 68-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 027L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 14-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 14-Jan-2021, the patient experienced VACCINATION SITE PAIN (Soreness in arm of injection) and VACCINATION SITE ERYTHEMA (Redness in arm of injection). On 18-Jan-2021, VACCINATION SITE PAIN (Soreness in arm of injection) and VACCINATION SITE ERYTHEMA (Redness in arm of injection) had resolved.        mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosing remained unchanged.       Concomitant product use was not provided by the reporter.  No treatment information was provided.      This case was linked to MOD-2021-081517 (Patient Link).
Received the shots on 10/23/2008 at 19:45 pm.  After 24 hours developed itching and swelling of the forearm that extended to the entire arm. The are also became warm after 48 hrs. The swelling subsided after two weeks. She was only given Ibuprofen syrup
The day after he got his first booster he had trouble walking.  Left leg was sore and now right leg is sore.  Has not gotten any better.  Can't stand long.
In 07/99, and on unspecified date, the vaccinee received the first and second doses of the vax. Post second vax, on approximately 08/13/99, the vaccinee experienced severe fatigue and severe soreness at the injection site. Additionally, he experienced severe joint soreness of the fingers, knees, ankles, wrists, and other joints. The vaccinee had worsening of symptoms in the morning, and his symptoms improved as the day went on. Additionally he experienced lightheadedness and a feeling of tightness in the joints. He received systematic treatment with OTC analgesics. The most recent information, received on 03/14/2000, reports the condition of the pt as unknown.
Pt reported increasing discomfort after receiving vaccinations in R deltold on 3/3/15. Pain awakened her night of 3/4 and she noticed redness and swelling. Redness and swelling increased and pt was seen in ER 3/5 and dx'd with cellulitis and early abscess. I/D performed and discharged with Clindamycin oral. Pt returned to ER 3/7 with complaints of worsening rednss/pain and Bactrim DS bid for 7 days was added to regimen. Pt has pending f/u with PMD 3/12.
Aneurysm; red splotches on arm skin; A spontaneous report was received from a Consumer concerning a HCP, male patient of unknown age who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced developed red splotches on his arm skin and patient died from an aneurysm.  The patient's medical history was not provided. No concomitant medications were reported.  On an unknown date, prior to the onset of the events, the patient received their unknown of the two planned doses of mRNA-1273 (lot/batch: unknown) via unknown route for prophylaxis of COVID-19 infection.  On an unspecified date, after vaccination the patient had a reaction and developed red splotches on his arm skin.   Then four to five days, later in the hospital the patient died from an aneurysm (Seriousness criteria: death).  The cause of death was aneurysm. No autopsy details reported  No Laboratory investigations were provided. No Treatment information was provided.  Action taken with mRNA-1273 in response to the events was not applicable.   The outcome of aneurysm was fatal and for erythema was unknown.; Reporter's Comments: Very limited information regarding these events has been provided at this time.  Further information has been requested; Reported Cause(s) of Death: Aneurysm
10 days following vaccine (7/30/05) developed cramping abdominal pain, pulling legs up to abdomen. some loose bowel movement. No vomiting. Admitted for IVF, bowel rest. Resumed PO about 16 hours after admit. Discharged to home 8/1/05. Parents request VAERS completed. Felt to be mild gastroenteritis. 1/13/06 - Review of 17-page d/c summary. Final diagnosis was viral gastroenteritis and dehydration. Fever,  mild decrease in urinary output, increased fussiness, inconsolable crying, and generalized rash on body were noted.
12 hours after injection, experienced nausea, chills and overwhelming sleepiness. Reaction lasted until 10 am on Monday, April 26 when side effects began to gradually lessen. By 10 am, Tuesday, April 27 was feeling back to normal.
Seen and released by EMS  for "numbness to forehead"  02 saturation 99%.  Pulse 60  Blood pressure 136/80
Body aches; Chills; little bit nausea; Fever like 105 degree; This is a spontaneous report from a non contactable consumer (patient). A patient of unspecified age and gender received second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Solution for injection; Lot Number: ER8736), via an unspecified route of administration on 05May2021 as DOSE 2, SINGLE for covid-19 immunisation. The patient medical history and concomitant medications were not reported. Historical vaccine included first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Solution for injection; Lot Number: ER8732), via an unspecified route of administration on 13Apr2021 as DOSE 1, SINGLE for covid-19 immunisation. The patient had some of the side effects not like severe but like body aches, chills, little bit nausea and fever like 105 degree on an unspecified date. Consumer further stated that just wanted to know how long will these last and when are they supposed to be start getting better, that was only consumer want to ask. Consumer don't know if it was supposed to last for a day or couple of days or it will go away. The patient underwent lab tests and procedures which included pyrexia: 105 degrees centigrade on unspecified date. At the time of this report, the outcome of events was not recovered.  No follow-up attempts needed. No further information is expected.
Dermatitis. She had a red enlarged rash from her elbow to her shoulder. She came in on Thursday the 5th and still had the rash. Pt said it hurt.
28FEB91 fever 101, APAP given @ 5PM; 7P fever 103.7 mom called ER & brought pt in; 8PM in ER t107.7; rt ear dull & retracted started on ATB; Advised pt to have no more pertussis per MD;
Pt given second dose of HPV vaccine (CERVARIX) on 9/15/16. Returned to office on 10/18/16 to report experiencing flu-like symptoms and low grade fever (99/5) for a few days after receiving injection. Felt weak with stomach pain and lower back pain x 3-4 weeks afterward. Also getting hot flashes and chills since receiving vaccine.
Headache, Myalgia, Arthralgia, Fever, Diarrhea, NauseaVomiting, 3/15 now w/diarrhea, little joint pain, fatigue Narrative:  Other Relevant History:
Patient expressed burning sensation in throat / tingling on tip of tongue shortly after vaccine.  Was evaluated by MD, taken for observation. Dispo was to home.
Pt recvd HIB vax & had fever of 104, 105 which was not prevented by APAP;
I had the chills and was foggy the day after my vaccination. I also ended up with a headache that came and went throughout the day.
I experienced a very sudden and intense Gout flare up that caused and is still causing an unbearable swelling in my right foot and ankle.  I have not had a flare up of this intensity and severity for over 12 years.  My Gout has been successfully managed by Allopurinal for over 12 years and I have not experienced any significant events during this time.  This time includes over 20,000 miles on my road bicycle and dozens of days over 100 miles.  Never have I had a problem.  Last Tuesday, I received the second dose of the Pfizer vaccine and I have yet to be able to walk or sleep through  the night for six days and counting.  This adverse effect should be followed and researched.  I also will be requesting reimbursement for out of pocket expenses due to this event.
SORENESS ON THE INJECTION SITE; This spontaneous report received from a patient concerned a patient of unspecified age and sex. The patient's weight, height, and medical history were not reported.The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unk) dose was not reported, administered on 28-FEB-2021 for prophylactic vaccination. The batch number was not reported. The Company is unable to perform follow-up to request batch/lot numbers. No concomitant medications were reported. On MAR-2021, the subject experienced soreness on the injection site. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of soreness on the injection site was not reported. This report was non-serious.
swollen lymph node, soft to touch-no pain lower neck above collar bone-supraclavicular lymph nodes-left side-same side as vaccine injection
My arm was sore for over  a week. I had to go to the ER because I had shortness of breath. I had a sinus infection. Ive had ongoing sinuc infections since receiving the vaccine
malaise x 24hr, no fever;nausea;gen papular rash;variable size 1-2 scabbed;
tingling in his left little finger; had a limited range of motion in that arm; This case was reported by a pharmacist via call center representative and described the occurrence of tingling in a 52-year-old male patient who received Herpes zoster (Shingrix) for prophylaxis.   On 22nd October 2020, the patient received the 1st dose of Shingrix (intramuscular). On 22nd October 2020, less than an hour after receiving Shingrix, the patient experienced mobility decreased. On an unknown date, the patient experienced tingling. On an unknown date, the outcome of the tingling and mobility decreased were unknown.   It was unknown if the reporter considered the tingling and mobility decreased to be related to Shingrix.  Additional details were provided as follows: The patient received his first Shingrix vaccine. Within one hour, the patient started to experience tingling in his left little finger. The sensation continued to increase in intensity until the patient had a limited range of motion in that arm.  The reporter did not consent to follow-up.
Tingling of his left arm to his fingers. Yes symptoms are still occurring. PT has taken ibuprofen has not helped.
She would stare at something for a long time so I took her to the doctor and they told me she was having seizures; My daughter also grew very little after receiving the vaccination; she is losing lots of hair now; This spontaneous report was received from a consumer referring to his daughter, a 20-year-old female patient. Information regarding the patient's concurrent conditions was not provided. The patient had no relevant medical history. There were no concomitant medications.  On 28-JAN-2005, the patient was vaccinated with "one dose" of measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live (M-M-R II) for prophylaxis (reported as "recommended by the doctor"), route of administration reported as "shot" (strength, frequency, lot number and expiration date were not reported).        In June 2005 (also reported as "about 6 months after the vaccination"), the patient started having seizures. She would stare at something for a long time so she was taken to the doctor and they told them she was having seizures. It was reported that she would have to take seizure medication (KEPPRA) for the rest of her life. The patient also grew very little after receiving the vaccination and she was losing lots of hair. According to the reporter, the patient was completely fine and healthy before receiving this vaccine.  The patient was hospitalized overnight on an unknown date in 2015 (reported as "5 years ago") for seizures.  On unknown dates (reported as every other year), the tests electroencephalogram (EEG) and magnetic resonance imaging (MRI) were performed (results not provided).   It was also reported that the patient sought medical attention with neurologists and neurosurgeons.   At the time of reporting, the patient had not recovered from the events.  The causal relationship between measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live (M-M-R II) and all the reported events was unknown.   Upon internal review the events seizures and growth retardation were considered to be medically significant.
Patient reports, "dull minor pain in the left deltoid that radiates to elbow" after receiving the influenza vaccine on 09/26/2022. Per client, "the symptoms have persisted since receiving the vaccine". Patient presented to the Health Department on 11/03/2022 to inform a nurse about the situation. The nurse assessed the arm and stated, "there was no redness, swelling or tenderness".  The patient was encouraged to follow up with healthcare provider or the Health department if the symptoms persist.
High fever that Tylenol wouldn't help, chills, uncontrollable shivering, muscle cramps/spasms, extreme fatigue/lethargy,  loss of appetite, swollen glands, earache and congestion in right ear, acute joint pain, arm pain at injection site. All symptoms went away after 5-6 days.
BlurredVision, Myalgia & Syncope Narrative: Employee reports: "I took off work for one and a half hours" I'm fine today.
Chills, fever, extreme  migraine, muscle aches throughout body, and at sight of injection, stiff muscle, rash at sight of injection .
After the initial side effects of chills, fever, and body aches subsided I had hot flashes and night sweats every night for 5 weeks. Then breast pain and swelling began and breast tissue changes were confirmed on May 28 via ultrasound. Two weeks later I developed a blood clot in my left calf as confirmed by an ultrasound on June 11, 2021.  I believe this blood clot was provoked my the Moderna vaccine, as there were no other factors that could have provoked the blood clot.
Sharp shooting pain in the bend of the left arm (all the way around when in use or held a certain way). The arm gives out and can't grip a towel tight to wring out the water.
COVID 19 Treatment/ Rebound positive test; COVID 19 Treatment/ Rebound positive test; This is a spontaneous report received from a non-contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 29-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), on 26Sep2021 as dose 3 (booster), single (Batch/Lot number: unknown) at the age of 28 years for covid-19 immunisation; coviD-19 vaccine (COVID-19 VACCINE), as dose 1, single (Batch/Lot number: unknown) and as dose 2, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history was not reported. There were no concomitant medications. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant), outcome "not recovered" and all described as "COVID 19 Treatment/ Rebound positive test". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: (unspecified date) Positive; (01Aug2022) Positive, notes: Rebound positive test. Therapeutic measures were taken as a result of drug ineffective, covid-19. Clinical course: Patient received treatment for covid-19 form 24Jul2022 to 29Jul2022.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Information has been received from a health professional concerning a female who on 26-JAN-2007, received her first 0.5 ml subcutaneous dose of varicella virus vaccine live (Oka/Merck). On 26-FEB-2007, she received her second 0.5 ml subcutaneous dose of varicella virus vaccine live (Oka/Merck). It was indicated that on 08-FEB-2008, her antibody titer for varicella was negative. The patient sought medical attention at the physician's office. Current patient status was not reported. A product quality complaint was not reported. Additional information has been requested.